Top vaccine official forced out of FDA
The head of the US Food and Drug Administration department responsible for assuring the safety and effectiveness of vaccines has resigned, according to a resignation letter obtained by CNN.
Dr. Peter Marks, director of the agency's Center for Biologics Evaluation and Research, was given the choice to resign or be fired. Marks' resignation takes effect April 5.
The news of Marks' forced resignation was first reported Friday by The Wall Street Journal.
'It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies,' Marks wrote in his letter, referring to US Health and Human Services Secretary Robert F. Kennedy Jr.
In an email, an HHS official told CNN, 'If Peter Marks does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy.'
FDA's Center for Biologics Evaluation and Research is responsible for the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue and gene therapies.
Marks was instrumental in carrying out Operation Warp Speed, the federal government's Covid-19 vaccine development program. He has overseen the approval of more recent vaccines, including the first influenza vaccine for self- or caregiver-administration, providing a new option for protection against seasonal flu.
Marks' forced resignation and other recent moves by HHS drew a wave of warnings from health experts.
'This is what happens when you hire a 20 year virulent anti-vaccine activist who continues to deny the science that vaccines don't cause autism, and put him in a position of influence,' Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia and a vaccine adviser to the FDA, told CNN, referring to Kennedy. 'So what you're about to see is studies done, presumably under the imprimatur of the CDC, showing that vaccines cause autism. That's what you're about to see, because he will put in place people who will shoehorn data to make it look that way, which will create more fear, will create likely more people who will choose not to be vaccinated, and you'll just see more and more in the way of these outbreaks.'
Earlier this month, HHS asked the CDC to study vaccines and autism, despite strong evidence that vaccines do not cause autism.
Dr. Ashish Jha, dean of the Brown University School of Public Health and Covid-19 response coordinator during the Biden administration, said on X that Marks is a brilliant scientist who 'helped usher in scientific rigor and transparency into the FDA.'
Pushing him out makes 'the FDA dramatically weaker, less effective,' Jha wrote. 'This is not how we make America healthy.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Hundreds of CDC employees reinstated after being laid off
The Brief Over 460 CDC employees have been reinstated after April layoffs, mainly from public health divisions. Thousands of jobs remain unfilled, with no word on further reinstatements. RFK Jr. appointed eight new vaccine advisers, including controversial figure Dr. Robert Malone. ATLANTA - More than 460 employees at the Centers for Disease Control and Prevention (CDC) have been reinstated after being laid off earlier this year, the U.S. Department of Health and Human Services (HHS) confirmed Wednesday, according to the Associated Press. What we know The employees are among the approximately 2,400 CDC staffers let go in April, a move that sparked widespread backlash and legal challenges. According to HHS, the reinstated workers include 200 employees from the Center for HIV, Hepatitis, STD and Tuberculosis Prevention and another 150 from the Environmental Health division, which includes a lab focused on lead poisoning prevention. PREVIOUS STORIES Reactions to mass layoffs underway at Atlanta-based CDC 2,400 CDC jobs to be cut in HHS overhaul announced by Secretary Kennedy CDC to lose nearly 1,300 probationary employees under Trump's job cuts Former employees and public health advocates have criticized the layoffs for leaving vital public health positions vacant. Reese Williams, a former CDC worker, said the terminations affected key personnel. "They fired a lot of our scientists, a lot of our public health communicators, a lot of anybody to do with DEI, birth defects, anything to do with smoke and health, domestic abuse and domestic violence," Williams said. Williams says the 2,400 roles that were eliminated this year played a critical role in public health. "They took a part a lot of the funding for our global partners. Funding that goes for Ebola or for these diseases that don't necessarily effect us, but could effect us, they took away a lot of that," she said. This is the second wave of reinstatements. In February, about 180 employees who were laid off were later asked to return. Despite the new round of rehirings, thousands of jobs remain unfilled, and officials have not indicated if additional reinstatements are forthcoming. Employees say many vital positions are still left empty. "Eventually, we will all feel this. Even the ones who think they won't feel it. We're going to feel it," Reese said. Meanwhile, HHS Secretary Robert F. Kennedy Jr. has appointed eight new members to the federal vaccine advisory committee. The move follows his abrupt dismissal of the previous panel earlier this week. Among the new appointees is Dr. Robert Malone, a controversial figure known for spreading misinformation about COVID-19 and vaccines. RELATED STORIES RFK Jr.'s newest CDC vaccine panel includes critics of COVID shots, lockdowns Protest against CDC vaccine committee firings held at Atlanta headquarters RFK Jr. ousts entire CDC vaccine panel The committee advises the CDC director on how approved vaccines should be used nationwide.
Yahoo
36 minutes ago
- Yahoo
RFK Jr.'s latest big move could leave you paying more for vaccines
Health Secretary Robert F. Kennedy Jr. sent shockwaves through the scientific community this week when he fired all 17 members of the federal government's key vaccine advisory board, raising concerns that he might try to replace them with immunization skeptics. Those fears were confirmed for many on Wednesday when Kennedy unveiled eight new members who included some of the most prominent critics of the COVID-19 vaccines. The swap could have wide-reaching public health consequences. But one of the most straightforward impacts may be on consumers' wallets. That's because recommendations by the board — known as the Advisory Committee for Immunization Practices, or ACIP — determine which vaccines most insurance plans are required to cover at zero cost, such as inoculation against measles or your annual flu shot. If the new members decide to reverse the panel's old guidance, patients could find themselves paying out of pocket for vaccines that were once available for free. 'For the average person who has never heard of ACIP before, this could affect their access to vaccines,' said Jennifer Kates, a senior vice president at the healthcare think tank KFF. Created in 1964, ACIP is the official outside panel of medical experts responsible for advising the Centers for Disease Control and Prevention (CDC) on what to include on its lists of routine shots for both children and adults. While its recommendations aren't binding, federal officials have typically adopted them. As a result, the board's decisions carry enormous weight, affecting patients and parents, as well as the vaccines schools require for students. Over the years, the panel has played a growing role in determining insurance coverage as well. By law, shots recommended by ACIP must be covered by the free Vaccines for Children program, the Children's Health Insurance Program, Medicaid, and Medicare Part D. The Affordable Care Act also requires private insurers to pay for vaccines with no cost sharing if they have the panel's seal of approval. (Past administrations have said the rule only applies if the CDC also adopts the board's recommendation.) In a Wall Street Journal op-ed this week, Kennedy said his decision to replace the board was meant to fight a 'crisis of public trust' in vaccines by ridding the committee of what he described as 'persistent conflicts of interest.' (Kennedy's critics have argued that his allegations against ACIP's former members are unfounded.) His new picks for the panel include several figures who rose to national fame by casting doubt on the safety of COVID-19 vaccines. Among them is Dr. Robert Malone, an accomplished scientist who did pioneering work on mRNA technology but later attacked its use in shots during the pandemic and who was at one point banned from Twitter for spreading COVID misinformation. He'll be joined by Retsef Levi, an MIT business school professor who gained attention in 2023 for claiming there was 'indisputable evidence' that 'MRNA vaccines cause serious harm including death,' and Dr. Martin Kulldorff, who advocated letting COVID spread among younger Americans to achieve 'herd immunity' and was later let go from Harvard Medical after refusing to be vaccinated. In his announcement, Kennedy said that each new member of ACIP was 'committed to demanding definitive safety and efficacy data before making any new vaccine recommendations' — suggesting they'll be less likely to add new shots to the government's immunization schedules. But he added that the board will also 'review safety and efficacy data for the current schedule as well,' raising the possibility that it will scrap some of its old recommendations. Even before this week's shake-up, the government had already begun changing its recommendations on COVID shots. In May, the CDC dropped its recommendation that healthy pregnant women receive the vaccine and revised its guidance for young children, saying they should only receive it after consultation with a doctor. Private insurers could still choose to cover vaccines even if the federal government stops recommending them. Whether they will is less certain. 'That's territory we haven't really had to traverse before,' said KFF's Kates. Sarah Moselle, a vaccine market expert at the health industry consulting firm Avalere, said there may be some 'fragmentation' in how carriers approach the issue. Some may drop coverage entirely or begin requiring co-pays. But many 'do anticipate that they would continue to cover some vaccines,' even if they aren't required to, since it would 'add value' for their customers, she said. In theory, insurers could also have an incentive to maintain vaccine coverage since it could keep their patients healthier and reduce the costs of their care, though it's unclear exactly how those savings would stack up against the added expense of paying for shots. For many vaccines, the out-of-pocket cost might be relatively cheap for patients. But others could turn out to be steep. Take Gardasil, the HPV vaccine that has been the focus of growing safety concerns among patients despite studies suggesting they're unfounded. Some experts told Yahoo Finance they thought the shot could be a target for more scrutiny under Kennedy's new ACIP. Currently, the shot is covered by insurance because it's recommended for pre-teens through young adults. The CDC lists its full price at over $300 a dose. Even modest costs can dissuade patients from getting vaccinated, according to Loren Adler, associate director at the Brookings Institution's Center on Health Policy. 'We know that folks having to pay $10 for a vaccine limits the uptake somewhat,' he said. As a result, just a small increase in what patients have to pay out of pocket could have ripple effects on public health. One issue to keep an eye on, according to Moselle, is whether state governments step in to require more extensive insurance coverage of vaccines if the federal government walks back some of its recommendations. If they do, vaccine access could start to vary more by where patients happen to live. Jordan Weissmann is a senior reporter at Yahoo Finance. Click here for in-depth analysis of the latest health industry news and events impacting stock prices
Yahoo
40 minutes ago
- Yahoo
Breyers Ice Creams Recalled After Flavor Containing Life-Threatening Allergen Was Packaged as Another Flavor
6,668 cases of Breyers Chocolate Truffle Ice Cream across the United States have been recalled by Unilever Manufacturing The affected ice cream cartons actually contain Rocky Road Ice Cream, which contains almonds, a potentially "life-threatening" allergen The U.S. Food and Drug Administration announced the recall on June 10Over 6,600 cases of Breyers Ice Cream have been recalled amid concerns that the product is mislabeled and contains a "life-threatening" allergen. The U.S. Food and Drug Administration confirmed that 6,668 cases of Breyers Chocolate Truffle Ice Cream were voluntarily recalled by Unilever Manufacturing on June 2 in a Tuesday, June 10 statement. The cause for the recall was determined to be "undeclared allergens and mislabeled product." "Rocky Road Ice was packaged with Chocolate Truffle Ice Cream labeled tub and a Rocky Road Ice Cream lid. Tub said 'may contain tree nuts' the lid said it did contain almonds," the FDA clarified about the recall. is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! The FDA declared this a Class II recall, which is defined as "a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." A representative for Breyers commented on the recall in a statement shared with PEOPLE, saying, "Unilever in the U.S. is voluntarily recalling one lot of Breyers Chocolate Truffle 1.5 quart tubs after some were found to contain Rocky Road ice cream, which includes almonds not listed on the label." The statement continued: "People with an almond allergy should not consume the product due to risk of serious or life-threatening allergic reaction. The safety and quality of our products is our top priority. For more information, consumers can visit or call 1-800-931-2826." It is unclear where exactly the cases of ice cream were distributed across the United States. The FDA reported the distribution as targeting "distribution centers and retail locations across the U.S." Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Rocky Road is a flavor of ice cream that contains almonds. Although almonds are considered tree nuts, the label for Breyers Chocolate Truffle Ice Cream only says that the product "may contain tree nuts." The Breyers recall comes a few weeks after nearly 18,000 containers of Wells Dairy ice cream and frozen yogurt were recalled due to contamination with hard plastics. Wells Enterprises, which produces Wells Dairy products, was responsible for the recall, which targeted 22 different flavors of frozen desserts. Read the original article on People
